Pfizer Pill News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Health minister says the 700,000 units of Paxlovid should cover 3 per cent of the population.

With some caveats. cnn's elizabeth cohen explains. >> christine, paula, on wednesday the food and drug administration gave emergency use authorization to paxlovid, an antiviral pill made by pfizer. here's why it's important. in the early stages of covid there hasn't been much that people can do. there are monoclonal antibodies, but you have to get an infusion or shots which means you have to find a place to get those and that's been tough. this is a pill. theoretically once we have this drug in abundance, you should be able to call your doctor and be able to get a prescription. there are two i...

Unvaccinated people who made i think a very bad choice will get their immunity the hard way, will get it through an infection. if you combine those things and the fact that omicron is, in general, somewhat milder an illness than delta, you have the vast, vast majority of the people having some measure of immunity. you have a virus that still will be hanging around that is more mild. you will have enough testing. you will have more supply of some of the medicines that are available, particularly paxlovid, the pfizer pill, which will lower the probability of severe outcome. and we may find ourse...

Have the tools to stay open safely. >> there's also the news that peter laid out, too, ordering of another 10 million treatments for the anti-viral pfizer pill. how important is that? >> the thing about a covid pill it has ingredients taken from china and india and has to go along the supply chain and takes months to manufacture. this order placed now, we won't receive it for a month. unfortunately, we need the medications right now. there's going to be a delay. i would say while that is a great gesture, it's not enough for the moment that we're in. i would have liked to have heard from presid...

Studies, i think a key point here is these are preprints, and preprints are studies that have not yet been fully published. so it's easy to say, these studies are out here, but they still need to go through a vetting process, but i do think they look very encouraging. key point is they were looking at people who are doubly vaccinated. the message is not we don't have to worry about omicron. the message is for those people who are fully vaccinated even better for those who are boosted. omicron does not appear to be as deadly of a disease. with regards to the pill, it is a great new tool in our ...